These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30789840)

  • 41. Effect of body weight on efficacy and safety of direct oral anticoagulants in the treatment of patients with acute venous thromboembolism: a meta-analysis of randomized controlled trials.
    Di Minno MN; Lupoli R; Di Minno A; Ambrosino P; Scalera A; Dentali F
    Ann Med; 2015 Feb; 47(1):61-8. PubMed ID: 25665582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral Anticoagulants.
    Chan NC; Eikelboom JW; Weitz JI
    Circ Res; 2016 Apr; 118(9):1409-24. PubMed ID: 27126650
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is there a role for low-dose DOACs as prophylaxis?
    Cohen AT; Hunt BJ
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):187-193. PubMed ID: 31808883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Direct oral anticoagulants: now also for prevention and treatment of cancer-associated venous thromboembolism?
    Pabinger I; Riedl J
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):136-143. PubMed ID: 29222248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Novel Oral Anticoagulants for Acute Venous Thromboembolism: Is Warfarin Dead?
    Cohen AT; Granziera S; Veronese N; Zoppellaro G
    Semin Respir Crit Care Med; 2017 Feb; 38(1):29-39. PubMed ID: 28208196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Number needed to treat based on real-world evidence for non-vitamin K antagonist oral anticoagulants versus vitamin K antagonist oral anticoagulants in stroke prevention in patients with non-valvular atrial fibrillation.
    Briere JB; Bowrin K; Millier A; Toumi M; Wojciechowski P; Taieb V
    J Med Econ; 2019 Aug; 22(8):760-765. PubMed ID: 30969801
    [No Abstract]   [Full Text] [Related]  

  • 47. Major Bleeding and Hemorrhagic Stroke With Direct Oral Anticoagulants in Patients With Renal Failure: Systematic Review and Meta-Analysis of Randomized Trials.
    Raccah BH; Perlman A; Danenberg HD; Pollak A; Muszkat M; Matok I
    Chest; 2016 Jun; 149(6):1516-24. PubMed ID: 26836922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic efficacy of direct oral anticoagulants and vitamin K antagonists for left ventricular thrombus: Systematic review and meta-analysis.
    Kitano T; Nabeshima Y; Kataoka M; Takeuchi M
    PLoS One; 2021; 16(7):e0255280. PubMed ID: 34310654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review.
    Bejjani A; Khairani CD; Assi A; Piazza G; Sadeghipour P; Talasaz AH; Fanikos J; Connors JM; Siegal DM; Barnes GD; Martin KA; Angiolillo DJ; Kleindorfer D; Monreal M; Jimenez D; Middeldorp S; Elkind MSV; Ruff CT; Goldhaber SZ; Krumholz HM; Mehran R; Cushman M; Eikelboom JW; Lip GYH; Weitz JI; Lopes RD; Bikdeli B
    J Am Coll Cardiol; 2024 Jan; 83(3):444-465. PubMed ID: 38233019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist's perspective.
    Ravera M; Bussalino E; Fusaro M; Di Lullo L; Aucella F; Paoletti E
    J Nephrol; 2020 Jun; 33(3):483-495. PubMed ID: 32200488
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies.
    Raschi E; Bianchin M; Ageno W; De Ponti R; De Ponti F
    Drug Saf; 2016 Dec; 39(12):1175-1187. PubMed ID: 27696300
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extended Anticoagulation for VTE: A Systematic Review and Meta-Analysis.
    Mai V; Guay CA; Perreault L; Bonnet S; Bertoletti L; Lacasse Y; Jardel S; Lega JC; Provencher S
    Chest; 2019 Jun; 155(6):1199-1216. PubMed ID: 31174635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation.
    Trujillo TC; Dobesh PP; Crossley GH; Finks SW
    Pharmacotherapy; 2019 Jan; 39(1):94-108. PubMed ID: 30548542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
    Becattini C; Franco L; Beyer-Westendorf J; Masotti L; Nitti C; Vanni S; Manina G; Cattinelli S; Cappelli R; Sbrojavacca R; Pomero F; Marten S; Agnelli G
    Int J Cardiol; 2017 Jan; 227():261-266. PubMed ID: 27843050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral Anticoagulation for Atrial Fibrillation Thromboembolism Prophylaxis in the Chronic Kidney Disease Population: the State of the Art in 2019.
    Zhang L; Steckman DA; Adelstein EC; Schulman-Marcus J; Loka A; Mathew RO; Venditti FJ; Sidhu MS
    Cardiovasc Drugs Ther; 2019 Aug; 33(4):481-488. PubMed ID: 31165356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta-analysis.
    Ge Z; Faggioni M; Baber U; Sartori S; Sorrentino S; Farhan S; Chandrasekhar J; Vogel B; Qadeer A; Halperin J; Reddy V; Dukkipati S; Dangas G; Mehran R
    Cardiovasc Ther; 2018 Oct; 36(5):e12457. PubMed ID: 29971964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and Efficacy of DOACs in Patients with Advanced and End-Stage Renal Disease.
    Rogula S; Gąsecka A; Mazurek T; Navarese EP; Szarpak Ł; Filipiak KJ
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation].
    Di Lullo L; Barbera V; Bellasi A; Cozzolino M; Russo D; Otranto G; Santoboni F; Ronco C
    G Ital Nefrol; 2017 Apr; 34(2):58-73. PubMed ID: 28682563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expanding Indications of Nonvitamin K Oral Anticoagulants Beyond Nonvalvular Atrial Fibrillation and Venous Thromboembolism: A Review of Emerging Clinical Evidence.
    Hajra A; Ujjawal A; Ghalib N; Chowdhury S; Biswas S; Balasubramanian P; Gupta R; Aronow WS
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt A):102017. PubMed ID: 37544618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Real-world comparison of direct-acting oral anticoagulants and vitamin K antagonists in chronic kidney disease: a systematic review and meta-analysis.
    Xu R; Wu F; Lan J; Duan P
    Expert Rev Hematol; 2021 May; 14(5):493-502. PubMed ID: 33949923
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.